Embed Size (px)
Citation preview
SYNTHETICCANNABINOIDS
TRYPTAMINESThere was 1 iden�fica�on each of 4-OH-MET, 4-AcO-DMT, and 5-MeO-MiPT this repor�ng period. 4-OH-MET was iden�fied for the first �me during the first half of CY 2017.
CATHINONES
OPIOIDS/ANALGESICS
EMERGING THREAT REPORT 2017 Drug Enforcement Administra�onSpecial Testing and Research Laboratory
US Department of. . Justice
Drug Enforcement Admini
stra
tion
.
HALLUCINOGENS
Mid-Year
FOR OFFICIAL USE ONLY
The Special Tes�ng and Research Laboratory’s Emerging Trends Program compiled the data for this report through a query of archived seizure and analysis informa�on from drug evidence analyzed by the Drug Enforcement Administra�on’s laboratory system. This data is representa�ve of drug evidence seized and analyzed in the date ranges annotated. This is not a comprehensive list of all new psychoac�ve substances and is not representa�ve of all evidence analyzed
by DEA. This data is a mid-year snapshot of the new psychoac�ve substance market in the United States.
The term new psychoac�ve substance (NPS) describes a recently emerged drug that may pose a public health threat. This includes synthe�c cannabinoids, subs�tuted cathinones, phenethylamines, opioids, tryptamines, benzodiazepines, and a variety of other chemical classes. Due to the recent increase in seizures, fentanyl is also included in this report.
An iden�fica�on is made when authen�cated reference material is available for comparison. When reference material is not available, the drug evidence is iden�fied as “substance unconfirmed”. A single unit of drug evidence may have mul�ple sub-units. For the purposes of this document, each unit of drug evidence counts as one iden�fica�on regardless of the number of sub-units. Some seized drug evidence contains more than one ac�ve ingredient; therefore, more than one iden�fica�on can be made for a single unit.
Questions about this data are welcome and may be directed to the DEA Emerging Trends Program at
703-668-3300 or [email protected].
There were 2 iden�fica�ons each of 25C-NBOMe and
25I-NBOMe this repor�ng period.
26096
3332
1398664322111
FUB-AMB5F-MDMB-PINACA
ADB-FUBINACAMMB-CHMICAAB-FUBINACA
ADB-CHMINACAMDMB-FUBINACA
5F-AMBAB-CHMINACA
5F-UR-144AB-PINACAFUB-AKB48
SDB-0055F-AB-PINACA
FUB-144NM2201
546137
682218141310
5322
Fentanyl
Furanyl fentanyl
U-47700
Acryl fentanyl
Carfentanil
4-ANPP
Acetylfentanyl
4-FiBF
Methoxyacetylfentanyl
Butyryl fentanyl
3-Methylfentanyl
Tetrahydrofuran fentanyl
Fentanyl accounted for 65% of the opioid iden�fica�ons. Of the 546 fentanyl iden�fica�ons, fentanyl was found as the only controlled substance in
approximately 45% of the iden�fica�ons and was found in combina�on
with heroin in approximately 49% of the iden�fica�ons. Furanyl fentanyl
was the next most prominent opioid accoun�ng for approximately 16% of
the iden�fica�ons.
6125
126
N-Ethylpentylone
Dibutylone
THERE WERE 121 CATHINONE IDENTIFICATIONS THIS REPORTING
PERIOD. N-ETHYLPENTYLONE ACCOUNTED FOR APPROXIMATELY
50% OF THE IDENTIFICATIONS. DIBUTYLONE WAS THE NEXT
MOST PROMINENT CATHINONE ACCOUNTING FOR APPROXIMATELY
21% OF THE IDENTIFICATIONS.
THERE WERE 477 SYNTHETIC CANNABINOID IDENTIFICATIONS
THIS REPORTING PERIOD. FUB-AMB ACCOUNTED FOR APPROX.
55% OF THE IDENTIFICATIONS.
OTHERThere were 19 instances of unconfirmed substances during this
repor�ng period. Addi�onally, there were 18 iden�fica�ons of
e�zolam, 4 iden�fica�ons of DMAA and TFMPP, 2 iden�fica�ons
of 5-EAPB and methoxetamine, and 1 iden�fica�on each of 3-
fluorophenmetrazine, 4-MeOPP, 5-MAPB, 6-APB, deschloroketamine, and mitragynine.
4333
1111
4-CEC
α-PVP
TH-PVP
4-MeAPP
Ethylone
Pentylone
3,4-Methylenedioxy-α-PBP
4-Cl-α-PVP
4-F-α-PVP
4-MMC
No new synthetic cannabinoids were identified in the first half of CY
2017.
FUB-AMB has remained the most identified synthetic cannabinoid since the 4th quarter of CY 2016.
MMC = Methylmethcathinone PBP = Pyrrolidinobutiophenone
MeAPP = Methylethylaminopentiophenone PVP = Pyrrolidinovalerophenone
CEC = Chloroethcathinone
Tetrahydrofuran fentanyl and methoxyacetylfentanyl were
identified for the first time during the first half of CY 2017.
